INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
The carcinogenic properties of nitrosamines have been known for more than 50 years [1] and there are several nitrosamines that have been tested for carcinogenicity and have shown carcinogenic activities N-nitroso-dimethylamine (NDMA), N-nitroso-diethylamine (NDEA), N-nitroso-N-methyl-4-aminobutyric acid (NMBA), N-nitroso-diethanolamine (NDELA), nitroso-morpholine (NMOR), N-nitroso-N-methyl-N-ethylamine, and N-nitrosopyrrolidine (NPYR), being some of the well-known among these [2,3]. There are many more Nitrosamines are considered during the assessment as per ICH M7(R2), EMA guideline (current versions of EMA/369136/2020 & EMA/409815/2020) and Control of Nitrosamine Impurities in Human Drugs (Febuary-2021 Rev-1), as high potency mutagenic carcinogens referred to as compounds that are part of the “cohort of concern” and as such are classified as Class 1 impurities “known mutagenic carcinogens,” based on both rodent carcinogenicity and mutagenicity data [4]. In order to ensure that the presence of nitrosamine impurities in the medicinal products is mitigated as much as possible and controlled at or below a limit defined based on ICH M7(R2), EMA guideline (current versions of EMA/369136/2020 & EMA/409815/2020) and Control of Nitrosamine Impurities in Human Drugs (Febuary-2021 Rev-1). This review article reflects calculation for the control of nitrosamine impurities in drugs by considering lifetime daily exposure.
Keywords:
N-Nitrosamines, Cohort of Concern, ICH M7, Drugs, exposure
Cite Article:
"Control strategy of Nitrosamine impurities in Pharmaceutical Drugs", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 5, page no.j259-j264, May-2023, Available :http://www.ijnrd.org/papers/IJNRD2305949.pdf
Downloads:
000118752
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn